Live Chat

交易 BioNTech BNTX

BioNTech實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
日期  關閉 更改 更改(%): 開倉

最新新聞

Christine Voong 2024 Nov 15, 10:00

比特幣價格突破90,000美元後回落,特朗普政策與利率不確定性加劇市場波動

Christine Voong 2024 Nov 15, 08:15

亞洲股市現況:維持震蕩走勢,美國降息預期與中美經濟數據交織影響市場情緒

Christine Voong 2024 Nov 15, 05:45

特朗普計劃取消電動車稅收抵免,特斯拉股價下跌,但或將成為最大受益者

So Ze Dong 2024 Nov 15, 01:00

11月15日財經:美國股市選後漲勢消退,美聯儲政策即將轉向?

Christine Voong 2024 Nov 14, 10:00

美元兌日元突破156.00關口,日元走勢疲軟,市場聚焦即將發佈的經濟數據

Christine Voong 2024 Nov 14, 04:35

消費者物價指數符合預期,市場聚焦12月聯準會降息與股市走向

So Ze Dong 2024 Nov 14, 01:00

11月14日財經:10月美國通脹數據仍然處於高位,比特幣一度漲到93000

Christine Voong 2024 Nov 13, 10:00

美元指數創新高,比特幣價格回調,市場觀望消費者物價指數與通脹走向

聯絡方式

點差

0.7649

點差(%)

0.7744 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場開放

星期五

14:31 - 20:59

星期一

14:31-20:59

星期二

14:31-20:59

星期三

14:31-20:59

星期四

14:31-20:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

24827473920

流通股份

239740000

收益日期(下一個)

0000-00-00

現金殖利率 

2022-06-17

除息日

2022-06-02

遠期年股息率

0

遠期年現金殖利率

0

每股盈餘

-1.92

了解有關此金融工具的詳細資訊

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV 16+ head and neck cancers; BNT114 to treat triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, which is in Phase I clinical trial for non-small cell lung cancer. It develops BNT122, which is in Phase II clinical trial for first-line melanoma and in Phase I clinical trial to treat multiple solid tumors; BNT131 that is in Phase I clinical trial for multiple solid tumors; BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors; BNT151, BNT152, and BNT153 to treat solid tumors; BNT211 to treat multiple solid tumors, and BNT221 for pancreatic and other cancers; BNT311 which are in Phase II clinical trial to treat metastatic non-small cell lung cancer and Phase I/II clinical trial to treat multiple solid tumors; and BNT312, which is in Phase 2 clinical trial to treat multiple solid tumors, as well as ONC-392, which is in Phase III clinical trial to treat ovarian cancer and Phase I/II clinical trial to treat multiple solid tumors. It develops BNT321, an IgG1 monoclonal antibody in Phase I clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate in Phase I clinical trial for solid tumors; BNT322, which is in Phase I/Ib clinical trial for multiple solid tumors; and prophylactic vaccine for shingles, malaria, tuberculosis, HSV-2, and other infectious diseases. It has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd; and Ryvu Therapeutics S.A, as well as strategic partnership the Coalition for Epidemic Preparedness Innovations (CEPI) to strengthen africa's mrna vac

相關工具

資產
出售
購買
更改(%):
查看所有金融工具
Trustpilot
Live Chat